{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:53:12Z","timestamp":1771005192935,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1038\/72279","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:34:58Z","timestamp":1027672498000},"page":"177-182","source":"Crossref","is-referenced-by-count":53,"title":["Genetic correction of sickle cell disease: Insights using transgenic mouse models"],"prefix":"10.1038","volume":"6","author":[{"given":"Marie-Jos\u00e9","family":"Blouin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugues","family":"Beauchemin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"De Paepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Sorette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Bleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betty","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Nan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"Stamatoyannopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Trudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,2,1]]},"reference":[{"key":"BFnm0200177_CR1","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1172\/JCI105863","volume":"47","author":"JF Bertles","year":"1968","unstructured":"Bertles, J.F. & Milner, P.F. Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle-cell anemia. J. Clin. Invest. 47, 1731\u2013 1741 (1968).","journal-title":"J. Clin. Invest"},{"key":"BFnm0200177_CR2","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","volume":"332","author":"S Charache","year":"1995","unstructured":"Charache, S. et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N. Engl. J. Med. 332, 1317\u20131322 (1995).","journal-title":"N. Engl. J. Med"},{"key":"BFnm0200177_CR3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood.V84.1.339.339","volume":"84","author":"GJ Dover","year":"1994","unstructured":"Dover, G.J., Brusilow, S. & Charache, S. Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood 84, 339\u2013343 (1994).","journal-title":"Blood"},{"key":"BFnm0200177_CR4","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1182\/blood.V90.5.2075","volume":"90","author":"PG McCaffrey","year":"1997","unstructured":"McCaffrey, P.G., Newsome, D.A., Fibach, E., Yoshida, M. & Su, M.S.-S., Induction of \u03b3-globin by histone deacetylase inhibitors. Blood 90, 2075\u20132083 (1997).","journal-title":"Blood"},{"key":"BFnm0200177_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1056\/NEJM199301143280202","volume":"328","author":"SP Perrine","year":"1993","unstructured":"Perrine, S.P. et al. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the \u03b2-globin disorders. N. Engl. J. Med. 328, 81\u201386 (1993).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0200177_CR6","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/blood.V84.9.3198.3198","volume":"84","author":"G Stamatoyannopoulos","year":"1994","unstructured":"Stamatoyannopoulos, G. et al. Fetal hemoglobin induction by acetate, a product of butyrate catabolism. Blood 84, 3198\u2013 3204 (1994).","journal-title":"Blood"},{"key":"BFnm0200177_CR7","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1182\/blood.V89.11.4204","volume":"89","author":"RA Popp","year":"1997","unstructured":"Popp, R.A. et al. A transgenic mouse model of hemoglobin S Antilles disease. Blood 89, 4204\u20134212 (1997).","journal-title":"Blood"},{"key":"BFnm0200177_CR8","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.278.5339.876","volume":"278","author":"C Paszty","year":"1997","unstructured":"Paszty, C. et al. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science 278, 876 \u2013878 (1997).","journal-title":"Science"},{"key":"BFnm0200177_CR9","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1126\/science.278.5339.873","volume":"278","author":"TM Ryan","year":"1997","unstructured":"Ryan, T.M., Ciavatta, D.J. & Townes, T.M. Knockout-transgenic mouse model of sickle cell disease . Science 278, 873\u2013876 (1997).","journal-title":"Science"},{"key":"BFnm0200177_CR10","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1182\/blood.V86.6.2419.bloodjournal8662419","volume":"86","author":"ME Fabry","year":"1995","unstructured":"Fabry, M.E. et al. A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity . Blood 86, 2419\u20132428 (1995).","journal-title":"Blood"},{"key":"BFnm0200177_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/343183a0","volume":"343","author":"DR Greaves","year":"1990","unstructured":"Greaves, D.R. et al. A transgenic mouse model of sickle cell disorder. Nature 343, 183\u2013185 (1990).","journal-title":"Nature"},{"key":"BFnm0200177_CR12","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1002\/j.1460-2075.1991.tb04877.x","volume":"10","author":"M Trudel","year":"1991","unstructured":"Trudel, M. et al. Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD. EMBO J. 10, 3157\u20133165 (1991).","journal-title":"EMBO J."},{"key":"BFnm0200177_CR13","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/ki.1994.403","volume":"46","author":"ME De Paepe","year":"1994","unstructured":"De Paepe, M.E. & Trudel, M. The transgenic SAD mouse: a model of human sickle cell glomerulopathy. Kidney Int. 46, 1337\u20131345 (1994).","journal-title":"Kidney Int."},{"key":"BFnm0200177_CR14","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1182\/blood.V94.4.1451","volume":"94","author":"M-J Blouin","year":"1999","unstructured":"Blouin, M.-J., De Paepe, M. & Trudel, M. Altered hematopoiesis in murine sickle cell disease . Blood 94, 1451\u20131459 (1999).","journal-title":"Blood"},{"key":"BFnm0200177_CR15","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood.V84.9.3189.3189","volume":"84","author":"M Trudel","year":"1994","unstructured":"Trudel, M. et al. Sickle cell disease of transgenic SAD mice. Blood 84, 3189\u20133197 (1994).","journal-title":"Blood"},{"key":"BFnm0200177_CR16","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1172\/JCI117149","volume":"93","author":"L De Franceschi","year":"1994","unstructured":"De Franceschi, L., Saadane, N., Trudel, M., Brugnara, C. & Beuzard, Y. Treatment with oral clotrimazole blocks Ca2+-activated K+transport and reverses erythrocytes dehydration in transgenic SAD mice. J. Clin. Invest. 93, 1670\u20131676 (1994).","journal-title":"J. Clin. Invest."},{"key":"BFnm0200177_CR17","doi-asserted-by":"publisher","first-page":"7033","DOI":"10.1073\/pnas.86.18.7033","volume":"86","author":"T Enver","year":"1989","unstructured":"Enver, T., Ebens, A.J., Forrester, W.C. & Stamatoyannopoulos, G. The human \u03b2-globin locus activation region alters the developmental fate of a human fetal globin gene in transgenic mice. Proc. Natl. Acad. Sci. USA 86, 7033\u20137037 (1989).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0200177_CR18","doi-asserted-by":"publisher","first-page":"7636","DOI":"10.1128\/MCB.13.12.7636","volume":"13","author":"G Stamatoyannopoulos","year":"1993","unstructured":"Stamatoyannopoulos, G., Josephson, B., Zhang, J.-W. & Li, Q. Developmental regulation of human gamma-globin genes in transgenic mice. Mol. Cell. Biol. 13, 7636\u20137644 (1993).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm0200177_CR19","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood.V63.4.921.921","volume":"63","author":"DR Powars","year":"1984","unstructured":"Powars, D.R., Weiss, J.N., Chan, L.S. & Schroeder, W.A. Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia? Blood 63, 921\u2013926 (1984).","journal-title":"Blood"},{"key":"BFnm0200177_CR20","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1365-2141.1970.tb01647.x","volume":"19","author":"GR Serjeant","year":"1970","unstructured":"Serjeant, G.R. Irreversibly sickled cells and splenomegaly in sickle-cell anaemia. Br. J. Haematol. 19, 635\u2013641 (1970).","journal-title":"Br. J. Haematol."},{"key":"BFnm0200177_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJM199107043250103","volume":"325","author":"OS Platt","year":"1991","unstructured":"Platt, O.S. et al. Pain in sickle cell disease: Rates and risk factors. N. Engl. J. Med. 325, 11\u201316 (1991).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0200177_CR22","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","volume":"330","author":"OS Platt","year":"1994","unstructured":"Platt, O.S. et al. Mortality in sickle cell disease: Life expectancy and risk factors for early death. N. Engl. J. Med. 330, 1639\u20131644 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0200177_CR23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1056\/NEJM198801143180207","volume":"318","author":"CT Noguchi","year":"1988","unstructured":"Noguchi, C.T., Rodgers, G.P., Serjeant, G. & Schechter, A.N. Levels of fetal hemoglobin necessary for treatment of sickle cell disease . N. Engl. J. Med. 318, 96\u2013 99 (1988).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0200177_CR24","first-page":"946","volume":"16","author":"H Croizat","year":"1988","unstructured":"Croizat, H. & Nagel, R.L. Circulating BFU-E in sickle cell anemia: Relationship to percent fetal hemoglobin and BPA-like activity. Exp. Hematol. 16, 946\u2013949 (1988).","journal-title":"Exp. Hematol."},{"key":"BFnm0200177_CR25","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1182\/blood.V75.4.1006.1006","volume":"75","author":"H Croizat","year":"1990","unstructured":"Croizat, H., Billett, H.H. & Nagel, R.L. Heterogeneity in the properties of burst-forming units of erythroid lineage in sickle cell anemia: DNA synthesis and burst-promoting activity production is related to peripheral hemoglobin F levels. Blood 75, 1006\u20131010 (1990).","journal-title":"Blood"},{"key":"BFnm0200177_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/(SICI)1096-8652(199902)60:2<105::AID-AJH4>3.0.CO;2-Z","volume":"60","author":"H Croizat","year":"1999","unstructured":"Croizat, H. & Nagel, R.L. Circulating cytokines response and the level of erythropoiesis in sickle cell anemia. Am. J. Hematol. 60, 105\u2013115 (1999).","journal-title":"Am. J. Hematol."},{"key":"BFnm0200177_CR27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1365-2141.1980.tb08706.x","volume":"44","author":"BP Alter","year":"1980","unstructured":"Alter, B.P., Goff, S.C., Efremov, G.D., Gravely, M.E. & Huisman, T.H.J. Globin chain electrophoresis: A new approach to the determination of the G\u03b3\/A\u03b3 ratio in fetal haemoglobin and to studies of globin synthesis . Br. J. Haematol. 44, 527\u2013 534 (1980).","journal-title":"Br. J. Haematol."},{"key":"BFnm0200177_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3109\/03630268508997024","volume":"9","author":"WA Schroeder","year":"1985","unstructured":"Schroeder, W.A., Shelton, J.B., Shelton, J.R. & Auynh, V. High performance liquid chromatographic separation of the globin chains of non-human hemoglobins. Hemoglobin 9, 461 \u2013482 (1985).","journal-title":"Hemoglobin"},{"key":"BFnm0200177_CR29","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/clinchem\/39.5.820","volume":"39","author":"C-N Ou","year":"1993","unstructured":"Ou, C.-N. & Rognerud, C.L. Rapid analysis of hemoglobin variants by cation-exchange HPLC. Clin. Chem. 39, 820\u2013824 (1993).","journal-title":"Clin. Chem."},{"key":"BFnm0200177_CR30","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1101\/gad.1.9.954","volume":"1","author":"M Trudel","year":"1987","unstructured":"Trudel, M. & Costantini, F. A 3\u2032 enhancer contributes to the stage-specific expression of the human \u03b2-globin gene. Genes Dev. 1, 954\u2013961 (1987).","journal-title":"Genes Dev."},{"key":"BFnm0200177_CR31","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1128\/MCB.7.11.4024","volume":"7","author":"M Trudel","year":"1987","unstructured":"Trudel, M., Magram, J., Bruckner, L. & Costantini, F. UpstreamG\u03b3-globin and downstream \u03b2-globin gene domain in human erythroid cells. Mol. Cell. Biol. 7, 4024 \u20134029 (1987).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm0200177_CR32","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood.V61.3.530.530","volume":"61","author":"G Stamatoyannopoulos","year":"1983","unstructured":"Stamatoyannopoulos, G. et al. Monoclonal antibodies specific for globin chains. Blood 61, 530\u2013539 (1983).","journal-title":"Blood"},{"key":"BFnm0200177_CR33","first-page":"147","volume":"84","author":"LM Corash","year":"1974","unstructured":"Corash, L.M., Piomelli, S., Chen, H.C., Seaman, C. & Gross, E. Separation of erythrocytes according to age on a simplified density gradient. J. Lab. Clin. Med. 84, 147\u2013151 (1974).","journal-title":"J. Lab. Clin. Med."},{"key":"BFnm0200177_CR34","unstructured":"Bunn, H.F. & Forget, B.G. in Hemoglobin: Molecular Genetic and Clinical Aspects 690 (W.B. Saunders, Philadelphia, 1986)."},{"key":"BFnm0200177_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/cyto.990030606","volume":"3","author":"YR Kim","year":"1983","unstructured":"Kim, Y.R. & Ornstein, L. Isovolumentric sphering of erythrocytes for more accurate and precise cell measurements by flow cytometry. Cytometry 3, 419\u2013427 (1983).","journal-title":"Cytometry"},{"key":"BFnm0200177_CR36","unstructured":"Tycko, D.H., Metz, M.H., Epstein, E.A. & Grinbaum, A. Flow cytometric light scattering measurement of red cell volume and hemoglobin concentration. Appl. Optics 24, 1355\u2013 1365 (1985)."},{"key":"BFnm0200177_CR37","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1182\/blood.V68.2.506.506","volume":"68","author":"N Mohandas","year":"1986","unstructured":"Mohandas, N. et al. Accurate and independent measurement of volume and hemoglobin concentration of individual red cells by laser light scattering. Blood 68, 506\u2013513 (1986).","journal-title":"Blood"},{"key":"BFnm0200177_CR38","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1182\/blood.V74.1.442.442","volume":"74","author":"N Mohandas","year":"1989","unstructured":"Mohandas, N. et al. Automated quantitation of cell density distribution and hyperdense cell fraction in RBC disorders. Blood 74, 442\u2013447 (1989).","journal-title":"Blood"},{"key":"BFnm0200177_CR39","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/ajcp\/102.5.623","volume":"102","author":"C Brugnara","year":"1994","unstructured":"Brugnara, C. et al. Automated reticulocyte counting and measurement of reticulocyte cellular indices: Evaluation of the Miles H*3 blood analyzer . Am. J. Clin. Pathol. 102, 623\u2013 632 (1994).","journal-title":"Am. J. Clin. Pathol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0200_177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0200_177","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0200_177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:31:34Z","timestamp":1684452694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0200_177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["BFnm0200177"],"URL":"https:\/\/doi.org\/10.1038\/72279","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}